NorthCrest Asset Manangement’s Gossamer Bio GOSS Stock Holding History

NorthCrest Asset Manangement’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-297	Closed	-$4.16K	–	1020
2026 Q2	$4.16K	Sell	297 -12	-4%	-$268	﹤0.01%	929
2026 Q1	$9.13K	Buy	309 +165	+115%	+$20.7K	﹤0.01%	765
2025 Q4	$31.5K	Buy	+144	New	+$32.9K	﹤0.01%	813

Other funds holding GOSS

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

NorthCrest Asset Manangement's GOSS Position: Q3 2026 in Review

NorthCrest Asset Manangement sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 297 shares — an estimated $4.16K sold.

NorthCrest Asset Manangement first reported a position in GOSS in Q4 2025 and held it in 3 quarters. The position peaked at $31.5K in Q4 2025. 3 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

NorthCrest Asset Manangement reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
NorthCrest Asset Manangement sold 297 Gossamer Bio shares in Q3 2026, an estimated $4.16K.
NorthCrest Asset Manangement first reported a position in Gossamer Bio in Q4 2025 and held it in 3 quarters.
NorthCrest Asset Manangement's Gossamer Bio position peaked at $31.5K in Q4 2025.
3 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q3 2026, filed 13 Oct 2026.